The Biotech Devil’s Dictionary: Your guide to the inanities of industry jargon

This satirical dictionary peels apart the empty jargon and linguistic absurdities that biotech investors and entrepreneurs use to promote pet projects.

Biotech can be a breeding ground for jargon, coded language, and outright nonsense, as investors and scientists probe the depths of linguistic absurdity to explain why the thing they do is just that much more special than all the other things out there. We wanted to celebrate this proud tradition — and so, like a canny capitalist repurposing an old drug, we stole an idea.

Ambrose Bierce began “The Devil’s Dictionary” in the late 1800s, creating a satirical lexicon he updated weekly before wandering off to Mexico to die. We sought to replicate at least part of that story — hence, The Biotech Devil’s Dictionary. Entries appear semi-regularly in The Readout, our free daily biotech newsletter. (Shameless plug: Subscribe here!)

Here, in one place, are

You're reading a preview, sign up to read more.

More from STAT

STAT5 min readPolitics
Opinion: An Insider’s View Of The Myths And Misconceptions Behind 340B ‘Reform’
I hardly recognize the 340B drug discount program when I read the pharmaceutical industry’s criticisms about it. They say that 340B has grown too big, is without oversight and transparency, and is in desperate need of reform. Having spent more than a
STAT4 min readScience
Opinion: Barriers To Genomic Testing Get In The Way Of Precision Medicine
In this era of precision medicine, oncologists should be able to quickly check their patients' genomes. I was surprised to learn that many can't.
STAT3 min readSociety
Opinion: A New Approach Can Take Patient Safety To The Next Level
Doctors, nurses, and other hospital workers sometimes make mistakes. They can also anticipate them and prevent them from happening.